Agreement Signed Sample Clauses

The "Agreement Signed" clause establishes that the contract becomes effective only once all parties have signed it. In practice, this means that the rights and obligations outlined in the agreement are not enforceable until every required signature is obtained, whether in physical or electronic form. This clause ensures that there is a clear, mutual understanding of when the agreement takes effect, preventing disputes about the commencement of contractual duties or benefits.
Agreement Signed. The Company enters into an agreement that will result in a Change in Control.
View SourceView Similar (42)
Agreement Signed. Published - Distributed) a. This Agreement shall be signed by the officers and members of the Board as well as by the Association's officers and its negotiating team. b. This signed Agreement shall be published and distributed to all certificated/licensed personnel as close as possible to the date on which the Agreement goes into effect. c. The Association shall be provided with 250 copies of this Agreement, and the Board will be provided with 100 copies. d. The Board and the Association shall share the cost of publication of this Agreement equally. e. The Board shall provide all new and newly rehired CLSMs with a copy of this Agreement upon employment. Athletic/Activity Director - MS Asst. Athletic/Activity Supervisor - HS Asst. Athletic Director for Sports Medicine - Fall Asst. Athletic Director for Sports Medicine - Winter Asst. Athletic Director for Sports Medicine - Spring Asst. Athletic Trainer - HS - Fall Asst. Athletic Trainer - HS - Winter Asst. Athletic Trainer - HS - Spring Athletic Ticket Manager - HS - Fall Athletic Ticket Manager - HS - Winter Athletic Ticket Manager - HS - Spring Athletic Trainer -MS Audio Visual Coordinator - MS Audio Visual Supervisor - HS Authorized Clubs - Advisor Club - Art - MS Club - Bowling - MS Club - Chemistry - HS Club - Environment - WT Club - French Club - Games FF Club - Games FM Club - Games MS Club - Games WT Club - German Club - Jets Club - Leadership HS Club - Leadership MS Club - Math Counts Club - Power of the Pen - MS Club - Quiz Bowl - MS Club - Safety Patrol - WT Club - Ski Club - Spanish Club - Student Council - FF Club - Student Council - FM Club - Student Council - WT Authorized Clubs - Assistant Advisor Band Director Band Director - Assistant - MS Baseball - HS - Head Baseball - HS - Assistant Basketball - HS - Head Boys FR Basketball - HS - Head Boys VR Basketball - HS - Head Girls 0/ 0/ 00 0/ 0/ 00 0/ 0/ 00 1 0.700 5,839 5,955 5,955 1 1.000 8,342 8,508 8,508 1 0.700 5,839 5,955 5,955 1 0.700 5,839 5,955 5,955 1 0.445 3,712 3,786 3,786 1 0.409 3,412 3,480 3,480 1 0.409 3,412 3,480 3,480 1 0.340 2,836 2,893 2,893 1 0.363 3,028 3,088 3,088 1 0.363 3,028 3,088 3,088 1 0.363 3,028 3,088 3,088 1 640 640 640 1 0.340 2,836 2,893 2,893 2 0.222 1,852 1,889 1,889 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 1,523 1,523 1 0.179 1,493 ...
View Source
Agreement Signed. I understand that the peripatetic teachers work as a private company, using the premises of Bowdon Preparatory School.
View Source
Agreement Signed. This Agreement shall have been duly executed and delivered by all of Enviroplex Stockholders, and all the Enviroplex Stockholders shall have satisfied all of the conditions of this Section 5 and shall be prepared to close the transaction.
View Source
Agreement Signed. 10 (2) Notice of Intent to Seek Change in Control.......... 10 (3) Board Declaration................................... 10 (n)
View Source

Related to Agreement Signed

  • Vendor Agreement Signature Form (Part 1)

  • Transition Agreement 12.8.1 In the event of termination of this Agreement, whether in its entirety or with respect to the Terminated Territory, Ablynx and AbbVie shall negotiate in good faith the terms and conditions of a written transition agreement (the “Transition Agreement”) pursuant to which AbbVie and Ablynx will effectuate and coordinate a smooth and efficient transition of relevant obligations and rights to Ablynx as reasonably necessary for Ablynx to exercise its licenses pursuant to Sections 12.6 and 12.7 with respect to the Licensed Products after termination of this Agreement (in its entirety or with respect to the Terminated Territory, as applicable) as and to the extent set forth in this Article 12. For purposes of clarity, AbbVie shall not be required to Manufacture or have Manufactured the Licensed Products by or on behalf of Ablynx as part of the Transition Agreement. CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 12.8.2 The Transition Agreement shall provide that in the event of a termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3 or by Ablynx in its entirety pursuant to Section 12.2.1, AbbVie shall: (i) where permitted by Applicable Law, transfer to Ablynx all of its right, title, and interest in all Regulatory Documentation then Controlled by AbbVie and in its name applicable to the Licensed Products in the Territory that are the subject of an exclusive license grant in Section 12.6.1(iii); (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) unless expressly prohibited by any Regulatory Authority, transfer control to Ablynx of all Clinical Studies being Conducted by AbbVie as of the effective date of termination and continue to Conduct such Clinical Studies, […***…], for up to […***…] to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Ablynx shall not have any obligation to continue any Clinical Study unless required by Applicable Law, in which case Ablynx, if it wishes to terminate such Clinical Study, shall continue such Clinical Study […***…] until such time that Applicable Law allows such trial to be terminated (with Ablynx taking all reasonable steps to promptly terminate such Clinical Study and minimize all costs and expenses), and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, […***…]; (iv) assign (or cause its Affiliates to assign) to Ablynx all agreements with any Third Party with respect to the conduct of pre-clinical Development activities, Manufacturing or Clinical Studies for the Licensed Products, including agreements with contract research organizations, contract manufacturing organizations, clinical sites, and investigators, unless, with respect to any such agreement, such agreement (a) expressly prohibits such assignment, in which case AbbVie shall cooperate with Ablynx in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (b) covers Clinical Studies for Combination Products in which any active ingredient that is not a Licensed Compound is covered by Patents Controlled by AbbVie or any of its Affiliates or covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Licensed Products, in which case AbbVie shall, […***…], cooperate with Ablynx in all reasonable respects to facilitate the execution of a new agreement between Ablynx and the applicable Third Party; and (v) transfer to Ablynx all existing clinical supplies of the Licensed Compound or Licensed Product in the possession of AbbVie at the time of termination, which shall be […***…]. CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. In the event this Agreement is partially terminated or terminated in its entirety by Ablynx pursuant Section 12.2.1, then any actions or activities set forth in the Transition Agreement shall be […***…]. 12.8.3 The Transition Agreement shall provide that in the event of a termination of this Agreement with respect to a country or other jurisdiction by AbbVie pursuant to Section 12.3.2 or with respect to a Terminated Territory by Ablynx pursuant to Section 12.2.2 (but not in the case of any termination of this Agreement in its entirety), AbbVie shall in a reasonable amount of time following Ablynx’s request: (i) where permitted by Applicable Law, transfer to Ablynx all of its right, title, and interest in all Regulatory Approvals owned by AbbVie and then in its name that is solely applicable to the Terminated Territory and to the Licensed Products that are the subject of an exclusive license grant in Section 12.7.2, as such Regulatory Approvals exists as of the effective date of such termination of this Agreement with respect to such Terminated Territory; provided, that AbbVie retains a license and right of reference under any Regulatory Approval transferred pursuant to this clause as necessary or reasonably useful for AbbVie to Commercialize Licensed Products in the Territory, Develop Licensed Products in support of such Commercialization, or Manufacture Licensed Products in support of such Development or Commercialization; (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) grant Ablynx a right of reference to all Regulatory Documentation then owned by AbbVie and in AbbVie’s name that are not transferred to Ablynx pursuant to clause (i) above that are necessary or reasonably useful for Ablynx, any of its Affiliates or sublicensees to Develop or Commercialize any Licensed Products that are the subject of the license grant in Section 12.7.2, as such Regulatory Documentation exists as of the effective date of such termination of this Agreement with respect to such Terminated Territory.

  • Termination Agreement 8.01 Notwithstanding any other provision of this Agreement, WESTERN, at its sole option, may terminate either a Purchase Order or this Agreement at any time by giving fourteen (14) days written notice to CONSULTANT, whether or not a Purchase Order has been issued to CONSULTANT. 8.02 In the event of termination of either a Purchase Order or this Agreement, the payment of monies due CONSULTANT for work performed prior to the effective date of such termination shall be paid within thirty (30) days after receipt of an invoice as provided in this Agreement. Upon payment for such work, CONSULTANT agrees to promptly provide to WESTERN all documents, reports, purchased supplies and the like which are in the possession or control of CONSULTANT and pertain to WESTERN.

  • Executed Agreement The Offerors shall have received from the Placement Agents an executed copy of this Agreement.

  • Client Agreement We are not required to enter into a written agreement complying with the Code relating to the services that are to be provided to you.